CSPC Pharmaceutical Group Limited (08372.HK) announced annual results, with a attributable to equity shareholders of HK$9.46 million in net profit, representing a year-on-year increase of 20.43%.

Zh tng cijng APP xn, Jn bi yn jtun (08372.HK) gngb jizh 2025 nin 3 yu 31 r zh nind de qun nin yj, shuy 9444.8 wn gngyun, tngb zngzhng 15.32%; gngs quny gdng yngzhn yl 946 wn gngyun, tngb zngzhng 20.43%; mi g yngl 1.18 gng xin. According to the news from the Wise Finance APP, Junbaiyan Group (08372.HK) announced its full-year performance as of March 31, 2025, with revenue of 94.48 million Hong Kong dollars, a year-on-year increase of 15.32%; the company's net profit attributable to equity shareholders was 9.46 million Hong Kong dollars, a year-on-year increase of 20.43%; earnings per share were 1.18 Hong Kong cents.